Showing results (481-490 of 1,026) with videos related to
Sort By:
Pageof 103
Anesthesia and Analgesia|March 22, 2024
Care of the Pediatric Patient for Ambulatory Tonsillectomy With or Without Adenoidectomy: The Society for Ambulatory Anesthesia Position StatementMarjorie P Brennan, Audra M Webber, Chhaya V Patel, et al.Veterinary Parasitology|January 7, 2011
Enhancement of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica by co-treatment with ketoconazoleC Devine, G P Brennan, C E Lanusse, et al.Veterinary Parasitology|April 17, 2016
Fasciola hepatica: a light and electron microscope study of the ovary and of the development of oocytes within eggs in the uterus provides an insight into reproductive strategyR E B Hanna, D Moffett, F I Forster, et al.Plos One|January 30, 2013
Transgenic overexpression of 14-3-3 zeta protects hippocampus against endoplasmic reticulum stress and status epilepticus in vivoGary P Brennan, Eva M Jimenez-Mateos, Ross C McKiernan, et al.European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|November 15, 2000
Dietary carotenoids and risk of gastric cancer: a case-control study in UruguayE De Stefani, P Boffetta, P Brennan, et al.Archives of Pathology & Laboratory Medicine|February 3, 1998
Immunohistochemical evaluation of merosin deficiency in congenital muscular dystrophiesF M Brett, P Loring, A Caesar, et al.Veterinary Parasitology|June 22, 2015
A comparative study on the impact of two artemisinin derivatives, artemether and artesunate, on the female reproductive system of Fasciola hepaticaJ F O'Neill, R C Johnston, L Halferty, et al.Parasitology Research|June 1, 2010
Enhancement of the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica using the metabolic inhibitor ketoconazoleCatherine Devine, Gerard P Brennan, Carlos E Lanusse, et al.Veterinary Parasitology|August 30, 2011
Potentiation of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica following its co-administration with the metabolic inhibitor, ketoconazoleC Devine, G P Brennan, C E Lanusse, et al.Journal of Environmental Quality|May 3, 2016
Holistic Evaluation of Field-Scale Denitrifying Bioreactors as a Basis to Improve Environmental SustainabilityOwen Fenton, Mark G Healy, Fiona P Brennan, et al.Pageof 103